Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

X
Drug Profile

SAB 176

Alternative Names: Anti-influenza human immunoglobulin - SAB BIO; SAB-176

Latest Information Update: 25 Jun 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SAB Biotherapeutics
  • Developer SAB BIO
  • Class Antivirals; Immunoglobulins
  • Mechanism of Action Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Influenza A virus H1N1 subtype
  • Phase I Influenza A virus infections; Influenza B virus infections

Most Recent Events

  • 20 Jun 2024 SAB Biotherapeutics is now called SAB BIO
  • 22 Apr 2024 Phase-I clinical trials in Influenza A virus infections (Prevention) in USA (IM) (NCT06435936)
  • 22 Apr 2024 Phase-I clinical trials in Influenza B virus infections (Prevention) in USA (IM) (NCT06435936)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days